Jensen-Group NV (JEN)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 73.20 |
|---|---|
| 52-week range | 56.40 – 89.80 |
| Return, 1 month / 3 months | −4.7% / −14.7% |
| Return, 1 year / 3 years | +19.7% / +137.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 32.9% |
| Worst drawdown (1 year) | -22.5% |
| Average daily value traded | 0.31M EUR |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jensen-Group NV designs and builds industrial laundry machinery and handling systems. Its equipment includes tunnel washers, ironers, folders and feeders used by commercial laundries, hospitals, hotels and other organisations that process large volumes of linen. The company is based in Belgium and supplies laundry operators and equipment partners in many countries, combining machines with automation and control systems for heavy-duty laundry work.
On this site Jensen-Group NV appears as a stock on the Euronext Brussels (Belgium), code JEN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jensen-Group NV (JEN) trades on the Euronext Brussels in Belgium. It last closed at EUR 73.20 on 22 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 54 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.7% and over the last three months it fell 14.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -16.1% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -14.7% | ||
| 6-month return | 5.4% | ||
| 12-month return, skipping the last month | 25.6% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.5% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.31M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −4.7% |
| 3 months | −14.7% |
| 6 months | +5.4% |
| 1 year | +19.7% |
| 3 years | +137.5% |
| 5 years | +193.0% |
Signals
| 50-day / 200-day average | 74.02 / 72.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.18 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 1.0500 |
| 26 May 2025 | EUR 0.7000 |
| 28 May 2024 | EUR 0.5250 |
| 24 May 2023 | EUR 0.3500 |
| 23 May 2022 | EUR 0.3500 |
| 26 May 2021 | EUR 0.1750 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.